Medical Radiation Detection, Monitoring & Safety Market Size, Share, Growth, and Industry Analysis, By Type (Gas-Filled Detectors,Geiger Muller,Solid-State), By Application (Radiology,Dental,First Aid,Nuclear Medicine,Other), Regional Insights and Forecast to 2035

Medical Radiation Detection, Monitoring & Safety Market

The global Medical Radiation Detection, Monitoring & Safety Market is forecast to expand from USD 968.86 million in 2026 to USD 1008.58 million in 2027, and is expected to reach USD 1390.97 million by 2035, growing at a CAGR of 4.1% over the forecast period.

The global Medical Radiation Detection, Monitoring & Safety Market has witnessed considerable growth, with the market size reaching approximately USD 2.00 billion in 2024, and gas-filled detectors accounting for about 43.5% of the market share in that year. In the detector segment, the gas-filled detectors led, followed by scintillators and solid-state detectors. The region of North America held about 35.5% share of the market in the base year, signifying its dominance in the industry. The increasing application of radiation in diagnostics and therapy, combined with rising awareness of occupational radiation safety, underpin the market dynamics.

Rigorous regulatory norms and heightened demand for protective equipment have contributed to equipment adoption across hospitals, clinics and ambulatory centres globally. The U.S. market recorded a dominant regional share, with the U.S. accounting for approximately 77.4% of the North American radiation detection, monitoring & safety market in 2023. Within that, the hospitals segment anticipated approximately 65.7% share of end-user demand in 2023. The U.S. medical radiation detection market was valued at about USD 294.0 million in 2023, with the gas-filled detectors segment capturing the largest portion in the country.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: ~43.5 % share for gas-filled detectors in 2024 market segmentation.
• Major Market Restraint: ~40.0 % of the global market cost pressure stems from high equipment and implementation cost
• constraints.
• Emerging Trends: ~64.5 % personal dosimeter share in medical radiation detection end-user deployments in 2023.
• Regional Leadership: ~35.5 % of the global market held by North America in 2024.
• Competitive Landscape: ~40.0 % of market share controlled by leading players in medical radiation detection, monitoring & safety industry.
• Market Segmentation: ~43.5 % detector segment (gas-filled) comprised of the leading detector technology in 2024.
• Recent Development: ~77.4 % U.S. share of the North American market in 2023 evidences U.S. leadership in medical radiation detection, monitoring & safety.

Medical Radiation Detection, Monitoring & Safety Market Latest Trends

Within the Medical Radiation Detection, Monitoring & Safety Market Industry Report framework, key trends indicate that detector technologies are shifting toward miniaturised, wearable dosimeters and real-time monitoring units. For instance, in 2023 the personal dosimeters segment registered about 64.5% share of product adoption in the U.S. owing to its precision monitoring capabilities in interventional radiology and nuclear medicine. In the global context, gas-filled detectors emerged as dominant in 2024 with about 43.5% share of detector types, underlining their cost-effectiveness ,

Geographically, Asia-Pacific is identified as the fastest-growing region with about 25.5% share during the forecast period, due to increased diagnostic imaging volumes and expanding healthcare infrastructure. Safety products such as full-body protection gear, face shields and hand safety equipment are garnering increased uptake, representing a shift from mere detection to comprehensive safety solutions. In terms of regulatory influence, the U.S. market of detection.

Medical Radiation Detection, Monitoring & Safety Market Dynamics

DRIVER

"Increased use of diagnostic imaging and radiation therapy"

One of the primary drivers for the Medical Radiation Detection, Monitoring & Safety Market Industry Analysis is the increased utilisation of diagnostic imaging and radiation therapy in healthcare. For example, in a major developed region during the 12-month period ending January, there were about 48.4 million imaging tests, including plain radiography and X-rays, driving the demand for radiation monitoring and safety equipment. 

RESTRAINTS

"Cost-intensive adoption and infrastructure integration"

A significant restraint in the Medical Radiation Detection, Monitoring & Safety Market Outlook is the high cost of equipment and the expense of infrastructure integration. For example, gas-filled detector systems and full-body protective safety gear comprise a substantial portion of capital expenditure in hospitals, with these devices being a dominant detector type (~43.5% share in 2024). 

OPPORTUNITIES

"Emerging regional markets and technology innovation"

The Medical Radiation Detection, Monitoring & Safety Market Research Report highlights significant opportunities arising from emerging markets and technological innovation. In Asia-Pacific, the share is projected at approximately 25.5% during the forecast period, driven by rapidly improving healthcare infrastructure and rising diagnostic volumes.

CHALLENGE

"Complex compliance and shortage of trained specialists"

The Medical Radiation Detection, Monitoring & Safety Market Industry Analysis recognises regulatory complexity and workforce constraints as core challenges. The U.S. market, holding ~77.4% share of North America in 2023, reflects strong regulatory oversight which demands compliance with occupational safety and radiation-dose limits. 

Medical Radiation Detection, Monitoring & Safety Market Segmentation 

The Medical Radiation Detection, Monitoring & Safety Market is segmented by Type and Application, with detector types and end-use applications driving distinct demand patterns: detector types contributed shares such as gas-filled ~43.5%, solid-state ~25.0% (estimated), and other detectors making up the remainder in 2024, while applications like Radiology ~48.4 million imaging tests and Nuclear Medicine ~increase in therapeutic procedures underpin usage figures. Regional segmentation shows North America ~35.5% share in 2024 and the U.S. ~77.4% of North America in 2023, influencing where product adoption is highest. 

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Gas-Filled Detectors: Gas-filled detectors — historically the backbone of clinical radiation monitoring — held the largest detector segment share at approximately 43.5% in 2024, driven by established use in area monitors and personal dosimeters and by low per-unit costs versus some solid-state options. These detectors remain preferred in many hospital inventory lists for routine area monitoring, accounting for a large installed base of devices in diagnostic radiology and nuclear medicine environments. 

Gas-Filled Detectors Market Size, Share and CAGR: The gas-filled detectors subsegment is estimated at ~USD 0.87B equivalent in 2024, representing ~43.5% share with an estimated 6.5% CAGR through the near term (estimate based on detector split and overall market forecasts). 

Top 5 Major Dominant Countries in the Gas-Filled Detectors Segment

• United States — estimated market size ~USD 0.67B, ~24% global share, CAGR ~6.0%, driven by hospital adoption and regulatory surveillance programs. 
• Germany — estimated market size ~USD 0.12B, ~4.3% share, CAGR ~5.5%, reflecting strong diagnostic imaging infrastructure. 
• Japan — estimated market size ~USD 0.10B, ~3.6% share, CAGR ~5.2%, due to high per-capita imaging volumes. 
• China — estimated market size ~USD 0.08B, ~2.9% share, CAGR ~7.5%, from rapid infrastructure expansion. 
• United Kingdom — estimated market size ~USD 0.06B, ~2.1% share, CAGR ~5.0%, supported by national safety programs. 

Geiger-Müller: Geiger-Müller (GM) counters, a classic gas-filled technology, continue to serve niche clinical and non-clinical applications for surface contamination checks and quick area surveys, representing a sizeable installed footprint among hospital portable monitors with measurable yearly procurement volumes. GM devices are favored for simple contamination screening and decontamination workflows and are commonly stocked in radiopharmacy and nuclear medicine departments for routine checks. 

Geiger-Müller Market Size, Share and CAGR: The GM counter subsegment is estimated at ~USD 0.42B in 2024, around 21% share of the detector market, with an estimated 5.5% CAGR reflecting steady replacement and field use. 

Top 5 Major Dominant Countries in the Geiger-Müller Segment

• United States — estimated GM market ~USD 0.18B, ~8% share, CAGR ~5.0%, due to adoption in hospital and emergency response kits. 
• India — estimated GM market ~USD 0.06B, ~2.5% share, CAGR ~8.0%, from expanding diagnostic and radiopharmacy services. 
• Japan — estimated GM market ~USD 0.04B, ~1.8% share, CAGR ~4.5%, sustained by nuclear medicine operations. 
• China — estimated GM market ~USD 0.05B, ~2.0% share, CAGR ~7.0%, supported by decontamination and safety buys. 
• South Korea — estimated GM market ~USD 0.03B, ~1.3% share, CAGR ~5.0%, linked to strong imaging and nuclear sectors. 

Solid-State: Solid-state detectors — including silicon and semiconductor diode technologies — are gaining market traction due to improved energy resolution, smaller form factor for wearable dosimetry and better integration with software analytics; solid-state devices accounted for an estimated ~25% detector share in 2024 and are increasingly specified for advanced dose-monitoring and real-time patient exposure tracking. 

Solid-State Market Size, Share and CAGR: The solid-state subsegment is estimated at ~USD 0.50B in 2024, about 25% share, with an estimated 8.0% CAGR reflecting faster adoption of wearable and networked devices. 

Top 5 Major Dominant Countries in the Solid-State Segment

• United States — estimated solid-state size ~USD 0.28B, ~10% global share, CAGR ~8.5%, driven by early adoption of wearable dosimetry in interventional suites. 
• Germany — estimated solid-state size ~USD 0.06B, ~2.1% share, CAGR ~7.0%, supported by precision imaging policies. 
• Japan — estimated solid-state size ~USD 0.05B, ~1.8% share, CAGR ~6.8%, from high-technology imaging centres. 
• China — estimated solid-state size ~USD 0.04B, ~1.5% share, CAGR ~9.0%, as hospitals deploy modern monitoring systems. 
• United Kingdom — estimated solid-state size ~USD 0.03B, ~1.0% share, CAGR ~6.0%, propelled by NHS safety initiatives. 

BY APPLICATION

Radiology: Radiology accounts for the largest application footprint, with diagnostic imaging volumes in some developed countries exceeding 48.4 million imaging tests in a year, driving demand for area monitors, personal dosimeters and dose-management software. Radiology end-use typically represents the largest portion of purchases for detection and monitoring devices, reflecting frequent routine exposures and regulatory dose tracking obligations in hospitals and imaging centres. 

Radiology Market Size, Share and CAGR: Radiology application estimated market size equivalent ~USD 0.95B, ~45% application share, with an estimated 6.8% CAGR due to sustained imaging volumes. 

Top 5 Major Dominant Countries in the Radiology Application

• United States — estimated radiology application size ~USD 0.45B, ~18% global application share, CAGR ~6.5%, reflecting highest per-capita imaging rates. 
• Germany — estimated ~USD 0.10B, ~4% share, CAGR ~5.5%, due to broad hospital imaging networks. 
• Japan — estimated ~USD 0.09B, ~3.6% share, CAGR ~5.0%, high imaging throughput driving monitoring purchases. 
• China — estimated ~USD 0.12B, ~4.5% share, CAGR ~8.0%, from rapid expansion of diagnostic centres. 
• United Kingdom — estimated ~USD 0.05B, ~2.0% share, CAGR ~5.0%, national safety programs boosting demand. 

Dental: Dental applications, though lower in per-unit device spend, represent a high unit count of compact detectors and pocket dosimeters for small clinics; dental X-ray volumes and point-of-care imaging create routine demand for low-cost detectors and protective accessories, forming an important volume segment within the market. Dental clinics typically purchase simpler monitoring solutions, with uptake linked to private practice penetration and regulatory inspection frequency. 

Dental Market Size, Share and CAGR: Dental application estimated at ~USD 0.12B, ~5.5% share, CAGR ~5.0%, driven by clinic volumes and compliance needs. 

Top 5 Major Dominant Countries in the Dental Application

• United States — dental application ~USD 0.05B, ~2% share, CAGR ~4.5%, high private clinic density. :contentReference[oaicite:31]{index=31}
• Germany — ~USD 0.01B, ~0.4% share, CAGR ~4.0%, strong dental regulation. 
• Japan — ~USD 0.01B, ~0.4% share, CAGR ~3.8%, established dental clinics. 
• China — ~USD 0.02B, ~0.9% share, CAGR ~6.5%, increasing dental service uptake. 
• Brazil — ~USD 0.01B, ~0.3% share, CAGR ~5.5%, growing private dental market. 

First Aid: First Aid and emergency response applications include portable detectors and survey meters used by emergency departments and mobile units; these devices form a smaller but critical category where rapid screening capability is essential, particularly in trauma and contamination events, with procurement tied to national emergency preparedness budgets and hospital emergency planning. 

First Aid Market Size, Share and CAGR: First Aid application estimated at ~USD 0.08B, ~3.6% share, CAGR ~5.5%, reflecting steady emergency readiness purchases. 

Top 5 Major Dominant Countries in the First Aid Application

• United States — first aid application ~USD 0.03B, ~1.2% share, CAGR ~5.0%, due to large emergency medical services network. 
• United Kingdom — ~USD 0.01B, ~0.4% share, CAGR ~4.8%, emergency preparedness programs. 
• Germany — ~USD 0.01B, ~0.3% share, CAGR ~4.5%, robust civil defense procurement. 
• India — ~USD 0.01B, ~0.5% share, CAGR ~7.0%, growing EMS capabilities. 
• Australia — ~USD 0.005B, ~0.2% share, CAGR ~4.5%, due to regional emergency needs. 

Nuclear Medicine: Nuclear medicine is a high-value application area owing to routine use of radiopharmaceuticals for diagnostic PET/SPECT and therapeutic radionuclide treatments; this application demands sensitive detection, contamination monitors and specialized dosimetry products, and contributes a meaningful portion of spend on high-precision detectors and contamination control tools. Nuclear medicine departments often require frequent calibration and replacement of monitoring devices. 

Nuclear Medicine Market Size, Share and CAGR: Nuclear medicine application estimated at ~USD 0.30B, ~14% share, CAGR ~7.2%, due to rising therapeutic radionuclide use and PET volumes. 

Top 5 Major Dominant Countries in the Nuclear Medicine Application

• United States — nuclear medicine ~USD 0.13B, ~6% share, CAGR ~7.0%, leading in PET/theranostics installations. 
• Germany — ~USD 0.04B, ~1.8% share, CAGR ~6.0%, strong SPECT/PET infrastructure. 
• Japan — ~USD 0.03B, ~1.3% share, CAGR ~5.8%, advanced nuclear medicine use. 
• China — ~USD 0.05B, ~2.2% share, CAGR ~9.0%, rapid expansion of theranostics. 
• France — ~USD 0.02B, ~0.9% share, CAGR ~5.5%, significant hospital nuclear medicine units. 

Medical Radiation Detection, Monitoring & Safety Market Regional Outlook

The Medical Radiation Detection, Monitoring & Safety Market shows concentrated demand in North America (~35.5% share in 2024), accelerating uptake in Asia-Pacific (~25.5% share) and steady shares across Europe, Middle East & Africa and Latin America, driven by diagnostic imaging volumes, regulatory enforcement and hospital deployments. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America 

North America accounted for roughly 35.5% share of the global Medical Radiation Detection, Monitoring & Safety Market in the base year, reflecting broad hospital penetration and extensive regulatory oversight that mandate radiation monitoring across clinical settings. The United States represents the largest sub-market in the region, comprising approximately 77.4% of North America’s market and concentrating purchases of personal dosimeters, area monitors, contamination meters and full-body safety apparel across more than 6,000 hospitals and thousands of imaging centres. Canada contributes a notable portion through public health mandates and nuclear medicine units, while Mexico is expanding procurement as diagnostic imaging volumes rise. North America’s installed base skews toward gas-filled detectors (~43.5% detector share globally) and rising adoption of solid-state wearable dosimeters for interventional suites. 

North America Market Size, Share and CAGR: The North America segment is estimated at ~35.5% share of the global market in 2024, with regional forecasts showing an approximate 6.5–8.0% CAGR and steady unit replacement driven by hospitals and diagnostic centres. 

North America - Major Dominant Countries in the “Medical Radiation Detection, Monitoring & Safety Market”

• United States — estimated as the region’s leader with ~77.4% of North America, reflecting the largest installed base and highest imaging throughput, showing an anticipated ~7.0% CAGR for detector and dosimeter replacements. :contentReference[oaicite:3]{index=3}Canada — public health and hospital networks drive adoption, representing roughly ~10–12% of North America, with an estimated ~6.0% CAGR as nuclear medicine and PET deployments grow.
• Mexico — growing diagnostics infrastructure comprises about ~6–8% of North America, with faster modernization cycles and around ~8.0% CAGR in detector and monitoring purchases. 
• Puerto Rico — hospital and federal lab purchases account for roughly ~1–2% of North America, with steady replacement cycles and ~~5.0% CAGR in monitoring equipment. 
• Costa Rica — emerging medical imaging expansion yields ~~0.5–1.5% of North America share, with infrastructure investments producing an estimated ~6.5% CAGR in monitoring and safety buys. 

Europe 

Europe remains a major regional market driven by extensive hospital networks, national radiation safety programs and high per-capita diagnostic imaging utilization in Western Europe. The region’s market share sits behind North America and Asia-Pacific, representing a substantial portion of detector and safety product demand—particularly for gas-filled detectors and contamination monitors used in nuclear medicine and radiology departments. Western European countries report high compliance rates with occupational dose monitoring and therefore maintain regular calibration and replacement cycles for personal dosimeters, area monitors and contamination meters. Germany, the United Kingdom, France, Italy and Spain together account for the bulk of regional procurement, with specialized nuclear medicine centres and oncology hospitals requiring advanced contamination control and precise dosimetry. 

Europe Market Size, Share and CAGR: Europe holds an estimated ~25–30% share of the global market with regional forecasts indicating an approximate ~6.0–7.5% CAGR, driven by national safety mandates and hospital modernization programs. 

Europe - Major Dominant Countries in the “Medical Radiation Detection, Monitoring & Safety Market”

• Germany — largest European buyer with ~~8–10% global share, strong nuclear medicine and imaging infrastructure, showing an estimated ~6.0% CAGR in detection and monitoring procurements. 
• United Kingdom — central NHS procurement yields ~~6–8% global share, with national safety programs and ~~6.5% CAGR in device modernizations. 
• France — hospital and oncology centre investments account for ~~4–6% global share, with ~~5.8% CAGR in dosimetry and contamination monitoring. :contentReference[oaicite:12]{index=12}
• Italy — significant imaging volumes and nuclear medicine services produce ~~3–5% global share, with ~~5.5% CAGR in safety and detector buys. 
• Spain — public hospital networks contribute ~~2–4% global share, with an estimated ~5.0% CAGR for monitoring and protective equipment purchases. 

Asia-Pacific 

Asia-Pacific is the fastest-growing regional market in terms of unit demand, driven by expanding hospital capacity, rising per-capita imaging volumes and large-scale healthcare infrastructure investment in China, India and Southeast Asia. The region captured approximately 25.5% share in recent segmentation reporting and is characterised by rapid modernization of diagnostic and nuclear medicine services, increased procurement of personal dosimeters and growing interest in solid-state wearable detectors for interventional suites. China’s aggressive expansion of diagnostic centres, Japan’s high per-capita imaging use and India’s scaling hospital footprint together create a large addressable market for detector manufacturers and safety-equipment suppliers. Regional demand patterns favour a mix of low-cost gas-filled instruments for basic monitoring and higher-value solid-state devices for advanced clinical environments. 

Asia Market Size, Share and CAGR: Asia-Pacific accounts for ~25.5% share of the global market in base reporting, with projected ~7.0–9.0% CAGR driven by infrastructure expansion and diagnostic volume growth. 

Asia - Major Dominant Countries in the “Medical Radiation Detection, Monitoring & Safety Market”

• China — largest in APAC with ~~8–10% global share, high hospital build rates and PET/SPECT expansion driving an estimated ~8.5% CAGR for detectors and dosimeters. 
• Japan — high per-capita imaging gives ~~4–6% global share, with established nuclear medicine usage and ~~5.5% CAGR for precision detector upgrades. 
• India — rapidly expanding diagnostics produces ~~3–5% global share, with modernization programs and ~~9.0% CAGR in monitoring equipment demand. 
• South Korea — advanced imaging centres yield ~~1.5–3% global share, with ~~6.0% CAGR in solid-state and wearable dosimetry adoption. 
• Australia — national radiology networks and safety programs create ~~1–2% global share, with ~~5.5% CAGR for networked monitoring solutions. 

Middle East & Africa 

Middle East & Africa (MEA) represents a growing regional market where investments in tertiary care hospitals, oncology centres and diagnostic imaging are increasing demand for radiation detection and safety products. The region historically accounted for a smaller share relative to North America, Europe and Asia-Pacific, but recent capital spending on healthcare infrastructure—particularly in Gulf Cooperation Council (GCC) countries—has led to notable upticks in procurement of area monitors, contamination meters and personal dosimeters. MEA’s growth is driven by new hospital projects, regional radiotherapy centre installations and government programmes to upgrade nuclear medicine capabilities. Oil-rich nations prioritise advanced safety systems for industrial and medical radiation uses.

Middle East and Africa Market Size, Share and CAGR: MEA presently occupies an estimated ~6–8% share of the global market, with forecasted ~6.0–8.5% CAGR as infrastructure projects and oncology centre installations multiply across GCC and selected African states. 

Middle East and Africa - Major Dominant Countries in the “Medical Radiation Detection, Monitoring & Safety Market”

• Saudi Arabia — major GCC buyer with ~~2–3% global share, significant hospital and oncology expansions driving an estimated ~7.5% CAGR in detection and safety equipment purchases. 
• United Arab Emirates — healthcare investment yields ~~1.5–2% global share, with advanced tertiary centres and ~~7.0% CAGR for networked monitoring systems. 
• South Africa — regional medical hub for southern Africa (~~1.0–1.5% global share), steady procurement of dosimeters and survey meters at ~~5.5% CAGR. 
• Egypt — expanding diagnostic networks provide ~~0.5–1.0% global share, with growing radiotherapy units and ~~6.5% CAGR in monitoring buys. 
• Israel — advanced nuclear medicine and research hospitals (~~0.5–1.0% global share), with targeted ~~6.0% CAGR for precision detectors and dosimetry systems. 

List of Top Medical Radiation Detection, Monitoring & Safety Market Companies

• Landauer
• Mirion Technologies

Top two companies with highest share

Landauer :  Market leader in passive dosimetry with over 100,000 customers, more than 2,000,000 workers monitored globally, roughly 200 dosimetry laboratories in service and about 70 years of operational history. Landauer reports that approximately 78% of U.S. hospitals use its occupational dosimetry services.

Mirion Technologies :  Leading global provider across medical and nuclear segments with an extensive installed base and service footprint; Mirion employs about 2,800 people and operates in roughly 12 countries, and it markets wireless/on-demand dosimetry (Instadose® family) .

Investment Analysis and Opportunities

Investors evaluating the Medical Radiation Detection, Monitoring & Safety Market should consider non-revenue metrics that indicate structural opportunity: detector-type splits (for example, gas-filled detectors historically account for a plurality of detector units and solid-state devices are taking share), penetration rates in hospital portfolios (Landauer serves an estimated 78% of U.S. hospitals), and the size of addressable installed bases.

Capital allocation is attractive where numbers show recurring service cycles (dosimetry services track millions of monitored workers daily and tens of thousands of active dosimeters in circulation) and high replacement frequency for wearables and calibration consumables. Opportunities exist in software and connectivity (networked dose management and API integrations), where evidence shows rising adoption of on-demand wireless dosimeters that transmit via Bluetooth and cloud platforms — Mirion’s Instadose®VUE and similar products demonstrate this trend. 

New Product Development

Innovation in the Medical Radiation Detection, Monitoring & Safety Market is focused on miniaturisation, connectivity, real-time access and software-first ecosystems. Recent product developments show clear direction: wireless/on-demand dosimeters (Instadose® and Instadose®VUE) enable immediate dose reads via Bluetooth and web portals, eliminating mail-in delays and increasing read frequency for staff wearing an estimated hundreds of thousands of active personal devices in clinical programmes.

QA and therapy workflow vendors are launching integrated QA suites and novel detector materials (Sun Nuclear’s SunSILICON™ detectors and SunSCAN™ 3D water scanning systems demonstrate advances in detector performance and commissioning efficiency). Vendors are adding cloud analytics, automated reporting and e-learning integrations to support customer standardisation and compliance — products combining hardware plus analytics lower administrative overhead for radiation safety officers and hospital physicists. 

Five Recent Developments 

• Instadose®VUE wireless dosimeter (Mirion) — launched and promoted as an on-demand Bluetooth dosimeter providing immediate dose reporting and historical exposure access; targeted at interventional staff and occupational programs moving to instant access models. 
• SunSCAN™ 3D and SunSILICON™ detectors (Sun Nuclear) — CE marking and commercial rollout of next-generation water scanning and detector products for commissioning and QA workflows, with product adoption milestones noted across therapy centres. 
• Large installed-base service wins and order awards (Mirion) — recent public filings and financial disclosures referenced significant contract awards and installed-base service orders in 2024–2025 across Asia and modular reactor projects, indicating scale in medical and nuclear service operations.
• Milestone customer adoption (Sun Nuclear SRS MapCHECK) — Sun Nuclear announced reaching the 1,000th SRS MapCHECK customer milestone (patient-specific QA), demonstrating strong product penetration in radiation therapy QA workflows.
• Service footprint reinforcement (Landauer) — Landauer public materials cite over 100,000 customers, >200 dosimetry labs and monitoring of >2,000,000 workers, and ongoing lab network expansions to support global dosimetry demand. 

Report Coverage of Medical Radiation Detection, Monitoring & Safety Market

The report scope covers detector technologies, dosimetry services, safety apparel and integrated monitoring systems across hospital and non-hospital end users, with geographic split and technology segmentation. Coverage includes detector-type analysis (gas-filled, Geiger-Müller, solid-state), application analysis (radiology, dental, nuclear medicine, first-aid/emergency, other research and veterinary uses), and regional breakdowns .

The report also maps procurement pathways (group purchasing organizations, centralized health systems), replacement cycles and service contract types to help buyers and suppliers estimate addressable unit demand and service opportunities; for example, it tracks penetration rates such as Landauer’s cited presence in approximately 78% of U.S. hospitals and Mirion’s service/installed-base reach across multiple countries. 

Medical Radiation Detection, Monitoring & Safety Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 968.86 Million in 2026
Market Size Value By	USD 1390.97 Million by 2035
Growth Rate	CAGR of 4.1% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Gas-Filled Detectors Geiger Muller Solid-State By Application : Radiology Dental First Aid Nuclear Medicine Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample